ES2090880T3 - Procedimiento para anomerizacion de nucleosidos. - Google Patents

Procedimiento para anomerizacion de nucleosidos.

Info

Publication number
ES2090880T3
ES2090880T3 ES93306886T ES93306886T ES2090880T3 ES 2090880 T3 ES2090880 T3 ES 2090880T3 ES 93306886 T ES93306886 T ES 93306886T ES 93306886 T ES93306886 T ES 93306886T ES 2090880 T3 ES2090880 T3 ES 2090880T3
Authority
ES
Spain
Prior art keywords
nucleosides
anomerization
procedure
anomer
anomeric mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93306886T
Other languages
English (en)
Inventor
Thomas Charles Britton
Tourneau Michael Edward Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2090880T3 publication Critical patent/ES2090880T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA INCREMENTAR LA CANTIDAD DE NUCLEOSIDO BETA-ANOMERO DE UN NUCLEOSIDO ALFA-ANOMERO O MEZCLA ANOMERICA NO DESEADA DE NUCLEOSIDOS POR CONTACTO DEL ANOMERO O MEZCLA ANOMERICA CON UNA BASE HIDROXIDA EN UN DISOLVENTE ORGANICO.
ES93306886T 1992-09-01 1993-08-31 Procedimiento para anomerizacion de nucleosidos. Expired - Lifetime ES2090880T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93879192A 1992-09-01 1992-09-01

Publications (1)

Publication Number Publication Date
ES2090880T3 true ES2090880T3 (es) 1996-10-16

Family

ID=25471966

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93306886T Expired - Lifetime ES2090880T3 (es) 1992-09-01 1993-08-31 Procedimiento para anomerizacion de nucleosidos.

Country Status (15)

Country Link
US (1) US5420266A (es)
EP (1) EP0587364B1 (es)
JP (1) JP3462893B2 (es)
KR (1) KR100252451B1 (es)
AT (1) ATE138929T1 (es)
BR (1) BR9303658A (es)
CA (1) CA2105112C (es)
DE (1) DE69302977T2 (es)
DK (1) DK0587364T3 (es)
ES (1) ES2090880T3 (es)
GR (1) GR3020426T3 (es)
HU (1) HU214980B (es)
IL (1) IL106840A (es)
MX (1) MX9305301A (es)
TW (1) TW356472B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
US5869461A (en) * 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
US5633367A (en) * 1995-03-24 1997-05-27 Eli Lilly And Company Process for the preparation of a 2-substituted 3,3-difluorofuran
CA2171518A1 (en) * 1995-03-24 1996-09-25 Douglas Patton Kjell Process for the preparation of 2,2'-anhydro- and 2' -keto-1-(3', 5'-di-o-protected-.beta.-d-arabinofuranosyl) nucleosides
US6013790A (en) * 1996-09-25 2000-01-11 Board Of Regents University Of Nebraska-Lincoln Heavily fluorinated sugar analogs
US6248878B1 (en) * 1996-12-24 2001-06-19 Ribozyme Pharmaceuticals, Inc. Nucleoside analogs
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
PL359169A1 (en) 2000-05-26 2004-08-23 Idenix (Cayman) Limited Methods and compositions for treating flaviviruses and pestiviruses
KR100467016B1 (ko) * 2002-05-30 2005-01-24 삼성전자주식회사 반도체기판의 세정방법
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
KR20050035194A (ko) 2002-06-28 2005-04-15 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료용 2'-ｃ-메틸-3'-ｏ-ｌ-발린에스테르 리보푸라노실 사이티딘
AU2003298658A1 (en) 2002-11-15 2004-06-15 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
US7598373B2 (en) 2002-12-12 2009-10-06 Idenix Pharmaceuticals, Inc. Process for the production of 2-C-methyl-D-ribonolactone
RU2358979C2 (ru) * 2003-05-30 2009-06-20 Фармассет, Инк. Модифицированные фторированные аналоги нуклеозида
CN101023094B (zh) * 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
ES2725457T3 (es) 2004-09-14 2019-09-24 Gilead Pharmasset Llc Preparación de ribofuranosil pirimidinas y purinas 2'fluoro-2'-alquil-sustituidas u otras opcionalmente sustituidas y sus derivados
DE602005019626D1 (de) * 2005-03-04 2010-04-08 Fresenius Kabi Oncology Ltd Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'-difluor-d-ribufuranosylnukleosiden
US7781576B2 (en) 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
US7964580B2 (en) * 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) * 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
AR074897A1 (es) * 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
MX2011006890A (es) * 2008-12-23 2011-07-20 Pharmasset Inc Analogos de nucleosidos.
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
AP2012006535A0 (en) 2010-03-31 2012-10-31 Gilead Pharmasset Llc Stereoselective synthesis of phosphorous containing actives
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
ES2716158T3 (es) 2010-11-30 2019-06-10 Gilead Pharmasset Llc 2'-spiro-nucleótidos para el tratamiento de hepatitis C
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
CN102603838B (zh) * 2012-02-14 2015-02-18 江苏八巨药业有限公司 一种制备吉西他滨盐酸盐的方法
EA201690473A1 (ru) 2013-08-27 2017-03-31 ГАЙЛИД ФАРМАССЕТ ЭлЭлСи Комбинированный состав двух противовирусных соединений
AU2019296174B2 (en) 2018-06-29 2021-10-07 Changchun Changcheng Pharmaceutical Technology Co., LTD Phosphorus-containing prodrugs of gemcitabine
CN121949418B (zh) * 2026-04-01 2026-07-28 山东安弘制药有限公司 一种盐酸吉西他滨的制备方法

Also Published As

Publication number Publication date
DE69302977T2 (de) 1996-10-31
JP3462893B2 (ja) 2003-11-05
US5420266A (en) 1995-05-30
ATE138929T1 (de) 1996-06-15
KR100252451B1 (ko) 2000-04-15
DK0587364T3 (da) 1996-07-01
GR3020426T3 (en) 1996-10-31
TW356472B (en) 1999-04-21
CA2105112C (en) 2005-08-02
IL106840A0 (en) 1993-12-08
IL106840A (en) 1998-09-24
JPH06157571A (ja) 1994-06-03
KR940007053A (ko) 1994-04-26
MX9305301A (es) 1994-06-30
HU9302452D0 (en) 1993-11-29
CA2105112A1 (en) 1994-03-02
BR9303658A (pt) 1994-03-22
HU214980B (hu) 1998-08-28
HUT65137A (en) 1994-04-28
DE69302977D1 (de) 1996-07-11
EP0587364B1 (en) 1996-06-05
EP0587364A1 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
DK0587364T3 (da) Fremgangsmåde til anomerisering af nukleosider
BR9302429A (pt) Processo para a preparacao de um sulfonato de riboturanosila enriquecido do anomero alfa
BR9302428A (pt) Processo estereosseletivo a baixa temperatura para preparar um derivado enriquecido de riboturanosila alfa-anomero e o derivado obitdo
ES2107624T3 (es) Procedimiento de glucosilacion estereoselectivo.
NO932286L (no) Stereoselektiv anion-glykosyleringsprosess
IL106074A0 (en) Process for separating 2-deoxy-2,2-difluoro-d-ribofuranosyl alkylsulfonate anomers
ATE173738T1 (de) Alkylthioalkylavermectine sind aktive antiparasitäre wirkstoffe
YU42664B (en) Process for the manufacture of 5'-deoxy-5-fluoruridine
EP0647652A3 (en) Process for the production of saccharide polyesters by transesterification.
FI890612L (fi) Menetelmä 4-demetoksidaunomysinonin, joka on 4-demetoksidaunorubisiinin aglykoni, valmistamiseksi
KR910004644A (ko) 2-데옥시-2,2-디플루오로자일로스 유사체 및 그의 중간체의 제조방법
UA6313A1 (uk) Підсолоджуваюча композиція

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 587364

Country of ref document: ES

FG2A Definitive protection

Ref document number: 587364

Country of ref document: ES